Literature DB >> 31184871

X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case.

Jessica L Thomaston1, Yibing Wu1, Nicholas Polizzi1, Lijun Liu2,3, Jun Wang4, William F DeGrado1.   

Abstract

The amantadine-resistant S31N mutant of the influenza A M2 proton channel has become prevalent in currently circulating viruses. Here, we have solved an X-ray crystal structure of M2(22-46) S31N that contains two distinct conformational states within its asymmetric unit. This structure reveals the mechanism of adamantane resistance in both conformational states of the M2 channel. In the Inwardopen conformation, the mutant Asn31 side chain faces the channel pore and sterically blocks the adamantane binding site. In the Inwardclosed conformation, Asn31 forms hydrogen bonds with carbonyls at the monomer-monomer interface, which twists the monomer helices and constricts the channel pore at the drug binding site. We also examine M2(19-49) WT and S31N using solution NMR spectroscopy and show that distribution of the two conformational states is dependent on both detergent choice and experimental pH.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31184871      PMCID: PMC7405929          DOI: 10.1021/jacs.9b02196

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  63 in total

1.  Permeation and activation of the M2 ion channel of influenza A virus.

Authors:  J A Mould; J E Drury; S M Frings; U B Kaupp; A Pekosz; R A Lamb; L H Pinto
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

2.  The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers.

Authors:  K C Duff; R H Ashley
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

Review 3.  Influence of solubilizing environments on membrane protein structures.

Authors:  Timothy A Cross; Mukesh Sharma; Myunggi Yi; Huan-Xiang Zhou
Journal:  Trends Biochem Sci       Date:  2010-08-18       Impact factor: 13.807

4.  Rapid search for tertiary fragments reveals protein sequence-structure relationships.

Authors:  Jianfu Zhou; Gevorg Grigoryan
Journal:  Protein Sci       Date:  2014-12-31       Impact factor: 6.725

5.  Crystal structure of the drug-resistant S31N influenza M2 proton channel.

Authors:  Jessica L Thomaston; William F DeGrado
Journal:  Protein Sci       Date:  2016-05-17       Impact factor: 6.725

6.  Conformational plasticity of the influenza A M2 transmembrane helix in lipid bilayers under varying pH, drug binding, and membrane thickness.

Authors:  Fanghao Hu; Wenbin Luo; Sarah D Cady; Mei Hong
Journal:  Biochim Biophys Acta       Date:  2010-09-29

7.  Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.

Authors:  S Grambas; A J Hay
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

8.  Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.

Authors:  Yuki Furuse; Akira Suzuki; Hitoshi Oshitani
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

9.  Immobilization of the influenza A M2 transmembrane peptide in virus envelope-mimetic lipid membranes: a solid-state NMR investigation.

Authors:  Wenbin Luo; Sarah D Cady; Mei Hong
Journal:  Biochemistry       Date:  2009-07-14       Impact factor: 3.162

10.  The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue.

Authors:  Yajun Tang; Florina Zaitseva; Robert A Lamb; Lawrence H Pinto
Journal:  J Biol Chem       Date:  2002-08-14       Impact factor: 5.157

View more
  7 in total

1.  Influenza AM2 Channel Oligomerization Is Sensitive to Its Chemical Environment.

Authors:  Julia A Townsend; Henry M Sanders; Amber D Rolland; Chad K Park; Nancy C Horton; James S Prell; Jun Wang; Michael T Marty
Journal:  Anal Chem       Date:  2021-11-23       Impact factor: 6.986

2.  Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.

Authors:  Olivier Terrier; Anny Slama-Schwok
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.

Authors:  Jessica L Thomaston; Athina Konstantinidi; Lijun Liu; George Lambrinidis; Jingquan Tan; Martin Caffrey; Jun Wang; William F Degrado; Antonios Kolocouris
Journal:  Biochemistry       Date:  2020-01-13       Impact factor: 3.162

4.  Spiers Memorial Lecture: Analysis and de novo design of membrane-interactive peptides.

Authors:  Huong T Kratochvil; Robert W Newberry; Bruk Mensa; Marco Mravic; William F DeGrado
Journal:  Faraday Discuss       Date:  2021-12-24       Impact factor: 4.394

5.  Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza.

Authors:  Claire Scott; Jayakanth Kankanala; Toshana L Foster; Daniel H Goldhill; Peng Bao; Katie Simmons; Marieke Pingen; Matthew Bentham; Elizabeth Atkins; Eleni Loundras; Ruth Elderfield; Jolyon K Claridge; Joseph Thompson; Peter R Stilwell; Ranjitha Tathineni; Clive S McKimmie; Paul Targett-Adams; Jason R Schnell; Graham P Cook; Stephen Evans; Wendy S Barclay; Richard Foster; Stephen Griffin
Journal:  PLoS Pathog       Date:  2020-08-11       Impact factor: 6.823

6.  Imidazole-Imidazole Hydrogen Bonding in the pH-Sensing Histidine Side Chains of Influenza A M2.

Authors:  Kumar Tekwani Movellan; Melanie Wegstroth; Kerstin Overkamp; Andrei Leonov; Stefan Becker; Loren B Andreas
Journal:  J Am Chem Soc       Date:  2020-01-30       Impact factor: 15.419

Review 7.  Put a cork in it: Plugging the M2 viral ion channel to sink influenza.

Authors:  Pouria H Jalily; Maggie C Duncan; David Fedida; Jun Wang; Ian Tietjen
Journal:  Antiviral Res       Date:  2020-03-27       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.